OPKO Health Announces Publication on Technology Underlying Blood Test for Alzheimer's Disease Jan 6, 2011
OPKO Announces Restatement of Financial Statements to Properly Account for Series D Convertible Preferred Stock; No Impact on Cash, Revenues or Other Results from Operations Nov 9, 2010
